by Mike Adams
July 27, 2015
Three Days Before U.S. Govt.
Raided the Research Facility of
he was Found Dead in a River.
The history of the suppression of
medical science in America is a long one, filled with true accounts
of pioneering doctors and clinicians being threatened, intimidated
even assassinated in order to bury emerging cures and keep the
"sick care" industry in control.
(The American Medical Association,
for example, has been
found guilty by the U.S. federal courts of a conspiracy to
destroy the chiropractic industry, by the way.)
Over the last few days, we've learned that before being found shot
in the chest and floating in the river, pioneering medical
researcher Dr. James Bradstreet was working with a little-known molecule
that occurs naturally in the human body.
Called, "GcMAF", this
molecule has the potential to be a universal cancer cure for
many people. It has also been shown to reverse signs of autism in
the vast majority of patients receiving the treatment.
While GcMAF is perfectly legal as a treatment in dozens of advanced
nations around the world, the U.S. Food and Drug Administration
outlawed it, calling it an "unapproved drug."
It is with this
designation - an effort to suppress the forward progress of medical
science - that the U.S. government conducted a raid on Dr.
Bradstreet's clinic, specifically seeking to confiscate GcMAF in
order to shut down his research and halt his treatment of patients.
Big Pharma gets
special permission to unleash untested, experimental drugs
on the public as long as those drugs earn sufficient profits.
In this article, I summarize the videos, articles and documents
covering GcMAF and the mysterious death of Dr. Bradstreet. An
exhaustive investigation needs to be pursued on this matter,
possibly involving private investigators.
The timing and manner of
Dr. Bradstreet's death seems highly suspicious, especially in light
of the many other holistic doctors who have recently been found dead
under mysterious circumstances. (Dr.
Gonzalez died just
Motive to murder medical researchers and
suppress a promising cancer treatment breakthrough
Is there a motive for the murder of
pioneering cancer researchers working on a possible universal
cancer cure? Of course there is... it's the most common motive
in the world: MONEY.
A universal cancer cure would destroy the profitability of the
highly lucrative cancer industry and collapse the American Cancer
Society, hospitals, oncology clinics and pharmaceutical companies
that depend on chemotherapy revenues to stay profitable.
their profitability is the inescapable fact that
conventional cancer treatments simply don't work most of the time,
creating a reliable profit stream of repeat business from patients
who are never cured (by design).
Would the cancer industry murder doctors to protect its profits? Of
course it would.
The industry kills patients as a routine part of
its business operations!
For example, an oncologist named
Farid Fata was recently
sentenced to 56 years in
prison for falsely diagnosing patients with cancer so that he
could sell them
chemotherapy treatments they didn't need.
article 'Cancer doctors 'fess up to making false diagnoses just to make more
INVESTIGATION - Here's what we know so
Multiple hat tips to all the outstanding
citizen journalists, video creators and bloggers who have created
the items cited below.
search warrant document served against Dr. Jeffrey Bradstreet to confiscate GcMAF from his research facility.
Below video that
connects the dots between Dr. Bradstreet, GcMAF, cancer cures and
the suppression of medical science by the U.S. government:
detailing the Dr. Bradstreet search warrant, served June 30,
during which the U.S. government seized GcMAF from Dr. Bradstreet's
EzekielDiet.com story that covers the apparent series of murders
of holistic doctors, many of whom are working on advanced treatment
protocols that render high-profit sectors of conventional medicine
Yet another doctor was just found murdered inside his home here on
the East Coast of Florida. This makes six doctors to be found dead
in the last month just from this region of the country alone.
out of the six were found dead here in Florida.
We lost the holistic
Dr. Teresa Sievers, MD, who was found murdered in her Florida home
just weeks ago. We've also lost the alternative Dr. Jeff Bradstreet,
MD, who was found in a river with a gunshot to his chest. He'd
recently moved to Georgia from Florida.
We've also lost the
Osteopath. Dr. Riley, who was found in Georgia at her home; just a
few hours from the Florida border. She was found with a gunshot
wound to her head.
Now we've lost Dr. Schwartz MD, who was found murdered in his home,
on Sunday, July 19th, 2015.
This was four weeks to the day after the
death of the first physician: (Dr. Bradstreet MD) who I broke the
story on a month ago. His family is still seeking answers as to what
happened to him and they're some of the kindest people I know.
latest MD, Dr. Schwartz, in the picture above, lived just north of
the fit, healthy, holistic Dr. Hedendal; who was the second doctor
to be found dead this past Father's Day, in Boca Raton. This was the
same day that Dr. Holt died at the age of 33.
Both were fathers; and
again, both men died here in Florida on June 21st, 2015.
SCIENCE.NaturalNews entry describing
of GcMAF in a published study:
Stepwise incubation of purified Gc protein with immobilized beta-galactosidase
and sialidase generated probably the most potent macrophage
activating factor (termed GcMAF) ever discovered, which produces no
adverse effect in humans...
After about 16-22 administrations (approximately 3.5-5 months) of
GcMAF, these patients had insignificantly low serum enzyme levels
equivalent to healthy control enzyme levels, ranging from 0.38 to
0.63 nmole/min/mg protein, indicating eradication of the tumors.
This therapeutic procedure resulted in no recurrence for more than 4
In other words, the administration of GcMAF
eradicated tumors and
left patients cancer-free for 4+ years with no additional treatment!
Both U.S. and UK governments desperately
seizing all supply
...shutting down clinics, even as millions die from
cancer every decade...
UK govt. admission that
GcMAF was on track to being
commercialized as a pioneering cancer treatment,
so they had to confiscate it!
GcMAF (Globulin component Macrophage Activating Factor), a blood
product, claims to treat a range of conditions including cancer, HIV
More than 10,000 vials were seized at this site and production of
this unlicensed medicine has now ceased. These products were sold
through various European websites and UK patients may have bought it
from one of these websites.
We are working with colleagues in other
countries to alert them to the potential risks. Our investigations
are ongoing and we have received no reports to date of side effects
caused by this product.
That same page lists some of the websites where GcMAF had been
available for purchase:
as a medical treatment in Japan.
GcMAF (Gc Protein derived Macrophage Activating Factor) - Gc MAF
treatment is a highly effective macrophage activating therapy, used
to stimulate the immune system and activate macrophages so that they
can destroy cancer cells and other abnormal cells in the body.
FAQ page of the treatment clinic:
What exactly is Second Generation GcMAF?
High Dose Second Generation Gc-MAF is produced using our new Patent
Pending process which was developed here in Japan by Saisei Mirai in
collaboration with Dr Hitoshi Hori and Dr Yoshihiro Uto at the
University of Tokushima who have been studying GcMAF for over 20
Studies on GcMAF began at the University of Tokushima in
1992, after they were introduced to Dr Nobuto Yamamoto's work and a
Second Generation GcMAF is made using a new and improved 2nd
generation method of Gc-MAF production which is 10-20 times more
concentrated and is more active and stable than other GcMAF that is
Importantly, this much higher concentration GcMAF has been clinically demonstrated to be largely free of any
side effects in the great majority of patients and is much more
stable because it is resistant to oxidation.
That same site describes Oral GcMAF as follows:
is a form of GcMAF produced from bovine colostrum by Saisei Mirai
which was developed in collaboration with Tokushima University."
It also lists the following health conditions as being treatable
with GcMAF, potentially a "universal cancer cure" substance:
Gc-MAF and/or oral Colostrum MAF macrophage activation therapy is
indicated in the treatment of any diseases where there is immune
dysfunction or where the immune system is compromised, such as:
Epstein-Barr Virus (EBV)
Hepatitis B virus (HBV)
Herpes Simplex virus (HSV)
Hepatitis C virus (HCV)
Multiple sclerosis (MS)
Urinary tract infection (UTI)
Autism Spectrum Disorders (ASD)
Rheumatoid arthritis (RA)
Chronic Fatigue Syndrome (CFS)
Lyme disease (Lyme borreliosis)
IgA deficiency disorder
Myalgic Encephalomyelitis (ME)
Human papillomavirus (HPV)
Lupus (Systemic lupus erythematosus, SLE)
Warts caused by viral infection
Malaria Influenza virus (flu)
Herpes simplex virus (HSV)
Q fever (Coxiella burnetii)
Polycystic ovary syndrome (PCOS)
Chicken pox (varicella zoster virus)
Respiratory tract infections
Ulcerative colitis, Crohn's disease
Type 1 diabetes (T1DM), insulin-dependent diabetes (IDDM)
Type 1.5 diabetes, Latent autoimmune diabetes of adults (LADA)
Do you see yet why
the medical establishment must
and destroy all knowledge of its clinical applications?
substance holds the potential to render numerous vaccines and
pharmaceuticals utterly obsolete.
GcMAF protein described at NaturalHealth365.com:
Researchers and practitioners have demonstrated that GcMAF can
reverse diseases that attack the immune system such as:
inflammation, bacterial and viral infections, chronic herpes,
chronic acne, Lyme disease, fibromyalgia osteoporosis, Hodgkin's,
Lupus, MS, Parkinson's and remarkably - autism.
A clinical study out of Italy on 94 children with autism showed that
83 of them made considerable progress while on GcMAF.
common reported improvements involve:
Cognitive abilities including attention and focus, learning and
understanding, receptiveness and awareness of the environment and
both receptive and expressive language gains.
Social Skills including willingness to interact and communicate
Behavior including less hyperactivity, less stereotypical
behaviors and improved cooperation and compliance.
In another study of 1500 children with autism, 85% had high levels
of viruses and a compromised immune system.
All 1500 received weekly GcMAF injections and 70% of the children responded to the treatment
with reduced symptoms and another 15% made full recoveries. The
other 15% did not respond.
It was stated that the reduction of autistic symptoms is permanent
provided that GcMAF has been taken long enough for the body to
produce its own GcMAF which typically takes 24 weeks.
The systematic suppression of medical
to protect the lucrative cancer treatment industry
(chemotherapy, oncology, radiotherapy, etc.)
ANH-EUROPE covers the systematic
suppression of advanced cancer treatments and cures:
Back in 1993, Nobuto Yamamoto, then working at Temple University
School of Medicine in Philadelphia, PA, USA, first described a
His paper reported the conversion of vitamin D3
binding protein (DBP, known in humans as Gc) into a potent
macrophage-activating factor (MAF), known as Gc-MAF.
a key part of the human immune system with two roles: to engulf and
destroy pathogens and cellular debris, and to recruit other immune
cells to respond to the pathogen.
Gc-MAF hasn't had the benefit of a single patent owner
- as a
natural molecule, it cannot be patented without being modified - with the will and resources to push it under the noses of the public
and health authorities. Dr Yamamoto has run small human trials in
breast, prostate and colorectal cancers, with promising results.
David Noakes might just be the person to bring Gc-MAF into the
He's the CEO of
Immuno Biotech Ltd. and spokesperson for
First Immune Gc-MAF, a project he describes as,
"PhD and BSc
biochemists and biomedical scientists... with external doctors,
oncologists and scientists who kindly provide advice, committed to
bringing some of the increasing number of published but relatively
unused medical cures to as many people as we can."
At the moment, Noakes and his colleagues are supplying Gc-MAF to 30 countries where
it is legal, via a network of "around 300" doctors. Their Gc-MAF is
made to extremely high standards, and is being used in ongoing
clinical research by Noakes' collaborators and others.
ultimate goal is to,
"Build the case that GcMAF is effective for
various illnesses, which will help to make it available to the
GcMAF suppliers fighting for survival
against a global medical monopoly that profits from disease
From the site:
The medical laws have been changed over the last 40 years so that
all the brilliant breakthroughs in cancer are denied to the British
Lord Maurice Saatchi had to watch his wife die, while his
doctor told him the only thing he was allowed to prescribe her was
chemotherapy, which would shorten her life. He hopes to bring the
Medical Innovation Bill to Parliament, so instead of obeying a
destructive government law, a doctor will be able to prescribe
whatever treatment is best for the patient...
Bad law kills, and Britain has the worst medical laws in Europe. The
1939 Cancer Act makes it illegal to discuss the possibility cancer
can be cured, which is partly why 160,000 people die unnecessarily
of cancer in Britain every year.
Science and treatments are decades
ahead of where the medical industry is today.
The MHRA's job is to
get life saving treatments like GcMAF out to people as quickly as
possible. Instead they block them to protect billion dollar Big
Pharma monopolies, who also fund the MHRA. Over a hundred thousand
lives could be saved every year if the 1939 Cancer Act were
repealed, and the MHRA were closed down.
There are 142 eminent scientists who have published GcMAF research
papers on the US National Library of Medicine alone.
how GcMAF works page:
Your GcMAF empowers your body to cure itself. In a healthy person
your own GcMAF has 11 actions discovered so far, including two on
cells, three excellent effects on the brain, and 6 on cancer.
Amongst these it acts as a "director" of your immune system.
viruses and malignant cells like cancer send out an enzyme called Nagalase that prevents production of your GcMAF: that stops its 11
beneficial effects, and neutralizes your immune system. So diseases
become chronic, and cancer cells grow unchecked.
Minutes after a receiving a dose, 10 of the body's actions restart.
In three weeks of two GcMAF 0.25ml doses a week, your immune system
is rebuilt to above normal strength. You need two doses a week for
typically 24 weeks for many diseases and early cancers, up to seven
one ml doses a week and a year for stage 4 cancers.
Your body then
takes the disease down without side effects, and successfully in 80%
of cases - depending upon how well you follow the protocol under
"Treatment Protocol" on this website.
What is GcMAF?
It is a human protein. One week's GcMAF looks like a small raindrop.
If properly produced it is perfectly sterile, and a most ethical
course for doctors.
GcMAF is therefore a replacement therapy for those who can't make
their own. Taking GcMAF replaces the missing part of the immune
system, and also acts as the body's own internal medicine.
GcMAF is extracted and isolated; its a 24 step process, and at the
end it must have tests to prove its sterility and activity. (If it
does not come with published tests, its probably not GcMAF.)
One GcMAF has been tested in universities, laboratories and clinics,
where, as a result of the testing, consistent activity and sterility
have always been found, and been the subject of 40 scientific
What does GcMAF do?
The GcMAF Conference 2013 showed GcMAF is a far more powerful
molecule than thought, both in terms of the science, and doctors'
In stage 4 cancer, some doctors who use the full protocol,
listed on "Treatment Strategies," are saving every patient (if they
have not had chemotherapy.) Success can be achieved with all tumor
cancers including breast, lung, prostate, pancreatic and melanoma.
GcMAF can eradicate chronic inflammation and viral infections.
better than antibiotics in many areas, and 25% successful with
Autism, 50% or more with,
...and various types of
Immune dysfunction including allergies.
Research shows GcMAF can
halt deterioration in Parkinsons, multiple sclerosis (MS), dementia
and ALS, and in its role of immune system regulator, can reverse
diseases that attack the immune system like Lupus and Arthritis. And
is effective with wound healing. Its successful with tumor cancers,
and some others.
In addition to rebuilding a depressed immune system, GcMAF:
Inhibits angiogenesis - stops blood supply to
Activates macrophages - phagocytosis and destruction of cancer cells
Apoptosis - suicide of cancer cells
Reverts the cancer cell phenotype to normal (Turns cancer cells into
Reduces the metastatic
potential of human cancer cells in culture
Increases energy production at the mitochondrial level
Improves human neuronal metabolic activity through cAMP signaling
- autism, ME/CFS, MS, ALS
Counters toxic effects including cadmium
It abolishes neuropathic pain due to neuro-oxidative stress (stress
due to the anti-cancer drug oxaliplatin) in the lab.
(neurodegenerative diseases and autism that have oxidative stress as
a pathogenetic mechanism)
It increases neuronal connectivity by promoting differentiation and
the formation of dendrites and neuritis (autism and ME/CFS, where
there is a lack of connectivity between neurons).
See the 31 research papers published, particularly Brescia, and the
60 published by others listed under "The science".
80% of terminal stage four
tumor cancers cases can be saved (40% if
they've had chemo), but usually when they are closely monitored,
which is why residential Treatment Centers are being run in
Switzerland. If they have three months to live and have not had
chemo, almost no one needs to be lost.
The 180 scientists who have published papers on trials of GcMAF
selected those in the early stages of cancer and HIV, and reported
nearly 100 percent success, with no recurrence after many years.
They did not attempt trials on people with large tumors.
Our trials are quite different: many people are over 50, some over
80, with advanced or terminal cancers, with significant tumor mass.
Most come to us when their doctors tell them they can do no more.
The life of GcMAF is only six days - you have to keep taking it
until your disease has gone (ie your nagalase is under 0.65
nmol/min/mg) then a further 8 weeks, or the immune system gets shut
How long should you take GcMAF for?
8 weeks for chronic herpes/acne, fibromyalgia, inflammation.
Allow 24 weeks plus of GcMAF for:
Autism (85% improve, 25%
CFS (70% eradication)
HIV, Lyme (8% respond, most
appear to have the VDR gene blocked and the viruses conceal
themselves with biofilms)
stage 1 to 2 cancer, (80% respond)
Late stage cancer, if you follow "Treatment Protocol" again has 80%
responders, but it takes a year to 18 months to become cancer free.
Cirrhosis of the liver: 16 months
Remember everyone responds differently. We can't say how you will
The more minor the disease, the easier it is for GcMAF to eradicate.
GcMAF needs normal levels of vitamin D to function strongly (take
10,000iu a day). in low responders, larger doses are required.
We have probably proved GcMAF can work for people up to age 90, and
can destroy large tumor mass. See "Participants experiences".
If you have your blood taken for monocyte counts, relevant markers
and vitamin D levels, and again for a nagalase test at the
beginning, you should see on your next test after three weeks that
your immune system is back to full strength, and after 8 weeks
significantly falling nagalase will indicate the disease is losing
Don't stop the GcMAF until your nagalase gets below 0.65
nmol/min/mg, when it loses the ability to prevent your body
producing your own GcMAF, and then you no longer need ours. Even
better, get scans.
Autism children can improve at five weeks with substantial
improvements at 8 weeks. See "Participants experiences." But
everyone is different.
The beauty of using your own immune system to attack disease or
cancer is that it remembers how to defeat it for the rest of your
life: it doesn't come back. And unlike chemotherapy, the side
effects are trivial.
The only way you can tell if GcMAF is genuine and active is to test
with living cells in a laboratory. See "Quality and Tests of our
We put live macrophages cells and MCF7 breast cancer cells together;
nothing happens. Then we add GcMAF; in 72 hours the macrophages eat
all the MCF7 cancer cells. We then put only GcMAF and MCF7 together,
and the GcMAF turns the cancer cells back into healthy cells.
We have GcMAF available for preclinical trials. See "Buy GcMAF".
You must read at least all of "Buy GcMAF" and "Treatment strategies"
on the left if you want to take this further. And you must be
prepared to give us feedback.
Patent document on GcMAF
Cancerous cells and HIV-infected cells secrete -N-acetylgalactosaminidase
into the blood stream, resulting in deglycosylation of serum Gc
protein. This inactivates the MAF precursor activity of Gc protein,
leading to immunosuppression...
When peripheral blood monocytes/macrophages
of 175 cancer patients bearing various types of cancer were treated
in vitro with 100 pg GcMAF/ml, monocytes/macrophages (phagocytes) of
all cancer patients were activated for phagocytic and superoxide
This observation indicates that patient
phagocytes are capable of being activated...
BetterHealthGuy.com coverage on GcMAF:
first heard about GcMAF almost a year ago.
At the same time, I had
first learned about "nagalase", a blood test that is used to in part
determine whether or not one might be a candidate for GcMAF therapy.
Nagalase is an enzyme that prevents Vitamin D receptors (VDR) from
being activated on the surface of the macrophage.
As a result,
macrophages are not "activated" and our immune systems are not able
to properly respond to invaders.
Here are some points that I have learned thus far on GcMAF:
GcMAF has reportedly been tested more for safety, purity, etc.
than other human blood products.
Macrophages are cultured, destroyed, and the GcMAF receptors are
Treatment is via injection 1x/week for 8-20 weeks. Dose is
titrated initially to avoid exacerbation or Herx responses as much
A commonly used dose is .25ml once weekly (a 2.2 ml vial should
last 8 injections).
The primary test used in looking at whether or not GcMAF may be a
reasonable intervention is nagalase.
Nagalase inactivates macrophages.
I personally would NEVER consider this option without having a
baseline nagalase test. Normal is < 0.95. Mine was 2.9.
The practitioner I worked with suggested that 2.9 was in the range
of someone with HIV or cancer in terms of the impact on the immune
I'd like to hear from others in the Lyme community as you
get test results as well to see if there is a pattern of elevated nagalase in those with Lyme disease. Whether or not Lyme itself has
anything to do with nagalase elevation is something I have not been
able to find anything on.
We certainly all have underlying viral
co-factors that are likely in play as well, but I suspect that Borrelia may also play a role in nagalase elevation.
In healthy college students, a nagalase 0.4 is not uncommon (the
lower the better).
At 2.9, my practitioner was surprised that I did not have more
cognitive deficits such as memory loss and other cognitive issues.
It has been suggested that ongoing antimicrobial therapy without a
working immune system is like leaving the house with the door wide
open inviting burglars in. By using GcMAF to activate macrophages,
nagalase drops, and one may regain a functional immune system. The
door is then closed to further invaders and we may no longer serve
as a microbe hotel.
Maintenance therapy should not be needed once the immune system is
once again properly functioning.
Activated macrophages only remain active for 7 days so any
negative responses are generally short-lived. That said, some people
do have strong inflammatory responses that are not believed to be
typical die-off reactions.
It has been indicated that in some cases, other medications may be
needed in order to manage the inflammatory response. This is another
reason that one needs to be working closely with a knowledgeable
practitioner before considering GcMAF in my opinion. In the CFS and
GcMAF world, this more severe form of a die-off reaction is called
VDR genetics do not seem to play a role in predicting response as
earlier thought according to one practitioner that I have spoken
with. That said, Vitamin D levels do correlate with the positive
response rate of GcMAF. Thus, Vitamin D supplementation may be
required in order to optimize outcome.
Other than die-off reactions or activation of symptoms
(inflammation), no other side effects are generally expected.
Nagalase should be monitored every 1-2 months while on treatment
to determine the required duration of the therapy. Target nagalase
after treatment would be 0.4 to 0.6.
Elevated nagalase has a profound detrimental effect on the immune
system. Elevated nagalase is often presumed to be related to
microbes of viral origin or cancer. Viruses that are nagalase
producers open the door to chronic infections.
Hemagglutinin contains nagalase and is also found in flagella of
some bacteria so it could also be the case that some bacteria may
Parents with ASD children also often have elevated nagalase.
A practitioner I spoke with likened Lyme disease to a "peat moss
fire" burning below the surface. Activating macrophages should help
to deal with the fire.
GcMAF should be helpful in dealing with other infections that are
not of viral origin; for example, Borrelia, Bartonella, and other
infections commonly associated with Tick-Borne Infections (TBIs).
GcMAF is active against many cancers and many different kinds of
Neopterin is another test that is sometimes used as an indicator
of immune suppression. As macrophages become activated, neopterin
may rise and later fall. If one is in the normal range for neopterin
and has an immune-related illness, this could be an indication that
the immune system is suppressed and not responding appropriately.
People with autoimmune conditions can generally use GcMAF.
However, GcMAF may be contraindicated in people with Multiple
Reduction in nagalase is generally seen early in the course of
treatment; within the first 3-6 weeks. In some studies, nagalase
dropped by over 50% in less than six weeks.
Cancer patients may initially feel as bad on GcMAF as they do on
chemotherapy, but often feel much better after the first month.
Anti-inflammatories may limited the effect of GcMAF.
Enzymes and biofilm-reducing supplements may have a negative
impact on GcMAF therapy and may be best avoided. It is still too
early to know what the impact may be, but one practitioner I spoke
with feels that it is best to avoid these.
One should not be on any immune-suppressing agents while on GcMAF
as the immune system must be partially functional in order to
respond appropriately to the treatment.
A common pattern is to see elevated lymphocytes, high nagalase,
and low NK cells. Once nagalase drops, it may be the case that NK
cell function could be positively impacted. CD57 is a type of NK
cell. It is too early to know if this proves to be true, but it is
one of the things I'm quite interested in.
video presentation on GcMAF therapy to learn more.
Read about GcMAF
Read The GcMAF Book at
Open the "Stop Fighting Cancer"
PDF document and search it for "GcMAF"
to read some intriguing passages:
Researchers testing GcMAF stated it,
"works 100% of the time to
eradicate cancer completely, and cancer does not recur even years
later." (This was stated based on the tested group of patients
- nothing works 100% for everyone)
The weekly injection GcMAF, a
harmless glyco-protein activates the human immune system which then
can kill the growing cancer.
Studies among breast cancer and colon
cancer patients produced complete remissions lasting 4 and 7 years
respectively. This glyco-protein 'cure' is totally without side
effect but currently goes unused and completely ignored by cancer
Why? Maybe it is because there is little money to be made
in selling it.
For less than $2,000 USD a cancer patient can obtain an
adequate amount of GcMAC.
See the National Library of Medicine page
Immunotherapy for Prostate Cancer with Gc Protein-Derived
Macrophage-Activating Factor, GcMAF:
When human macrophages were treated in vitro with 100 pg GcMAF/ml
for 3 hours and a prostate cancer cell line LNCaP was added with an
effector/target ratio of 1.5, approximately 51% and 82% of LNCaP
cells were killed by 4 and 18 hours of incubation, respectively.
This in vitro tumoricidal capacity of macrophages activated
by GcMAF led us to investigate the therapeutic efficacy of GcMAF for
GcMAF therapy as a single remedy modality can
eradicate metastatic breast and colorectal cancers most effectively...